Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1208

Lacto-N-triose II

Intended Use: Intended for use as an ingredient in formula intended for young children (> 12 months 3 years) and in drinks intended for young children at up to 0.03 g/L and in foods intended for young children at up to 0.25 g/kg; in dairy and non-dairy meal replacement drinks at up to 0.1 g/L; in sport, isotonic, and "energy" drinks, fortified waters and soft drinks, and in milk, flavored milk, and buttermilk at up to 0.05 g/L; in yogurt and grain-based bars at up to 0.5 g/kg; and in meal replacement bars for weight management at up to 1.0 g/kg.
Basis: Scientific procedures
Notifier: Shandong Henglu Biotechnology Co., Ltd.
Notifier Address: 25th floor, Block B, Jiaheng Business Building
Hualong Road, Licheng District
Shandong, Jinan
China
GRAS Notice (releasable information): GRN 1208 with amendments (in PDF) (12.9 MB)
Date of closure: Apr 29, 2025
FDA's Letter: FDA has no questions (in PDF) (285 kB)
-
-